These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7173571

  • 1. Clinical usefulness of serum cholylglycine determination in various liver diseases.
    Tanggo Y, Fujiyama S, Kin F, Tashiro A, Shiraoku H, Akahoshi M, Sato Y, Hashiguchi O, Sagara K.
    Gastroenterol Jpn; 1982 Oct; 17(5):447-52. PubMed ID: 7173571
    [Abstract] [Full Text] [Related]

  • 2. [Radioimmunoassay of cholylglycine in serum (author's transl)].
    Wakushima T, Yamanishi Y, Hirayama C.
    Radioisotopes; 1979 Jul; 28(7):437-40. PubMed ID: 504726
    [Abstract] [Full Text] [Related]

  • 3. [Determination of serum bile acids in hepatobiliary diseases. Clinical applicability].
    Pagani A, Pranzo A, Galante T.
    Minerva Med; 1984 Jan 28; 75(3-4):99-107. PubMed ID: 6700830
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of fasting serum bile acid in the long-term observation of chronic liver disease.
    Kishimoto Y, Hijiya S, Takeda I.
    Am J Gastroenterol; 1985 Feb 28; 80(2):136-8. PubMed ID: 3970000
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of enzymic and radioimmunoassay methods for measuring serum bile acids.
    Collins DM, Tisch G, Campbell CB.
    Pathology; 1980 Oct 28; 12(4):623-9. PubMed ID: 7465257
    [Abstract] [Full Text] [Related]

  • 6. [Determination of glycoconjugated biliary acids in the serum of chronic hepatitis patients and their correlation with liver function tests].
    Velo Bellver JL, Rabago Torre L, Fernández-Pacheco I, Castellanos D, Menchen PL, Clemente G, Senent C, López de la Riva M, Alcala Santaella R.
    Rev Esp Enferm Apar Dig; 1983 Nov 28; 64(5):382-8. PubMed ID: 6658130
    [No Abstract] [Full Text] [Related]

  • 7. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
    Andreuzzi B, Vai C, Santese R, Andreuzzi P, Cantoni L.
    Minerva Med; 1984 Mar 31; 75(13):749-56. PubMed ID: 6717831
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic value of serum cholylglycine radioimmunoassay in chronic asymptomatic HBsAg carriers.
    de Franchis R, Vecchi M, Primignani M, Bonato C, Parravicini A, Cambieri R, Ciaci D, Annoni G.
    Ric Clin Lab; 1983 Mar 31; 13(3):301-5. PubMed ID: 6648236
    [Abstract] [Full Text] [Related]

  • 9. Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.
    Adachi Y, Nanno T, Itoh T, Kurumi Y, Yamazaki K, Sawada Y, Yamamoto T.
    Gastroenterol Jpn; 1988 Aug 31; 23(4):401-7. PubMed ID: 3181666
    [Abstract] [Full Text] [Related]

  • 10. Increase of sulfated ursodeoxycholic acid in the serum and urine of patients with chronic liver disease after ursodeoxycholic acid therapy.
    Nakamura K, Yoneda M, Kimura A, Tamori K, Yokohama S, Sato Y, Kato T, Hasegawa T, Saito H, Aoshima M, Fujita M, Makino I.
    J Gastroenterol Hepatol; 1996 Apr 31; 11(4):385-90. PubMed ID: 8713707
    [Abstract] [Full Text] [Related]

  • 11. Clinical value of serum bile acid levels in chronic hepatitis.
    Jones MB, Weinstock S, Koretz RL, Lewin KJ, Higgins J, Gitnick GL.
    Dig Dis Sci; 1981 Nov 31; 26(11):978-83. PubMed ID: 7297378
    [Abstract] [Full Text] [Related]

  • 12. A study on detection of serum fasting total bile acid and choloyglycin in neonate for cholestasis.
    Guo W, Wu M, Pei X, Guan D, Xu L.
    Chin Med Sci J; 1996 Dec 31; 11(4):244-7. PubMed ID: 9387392
    [Abstract] [Full Text] [Related]

  • 13. Clinical evaluation of tissue plasminogen activator (t-PA) levels in patients with liver diseases.
    Okabe K, Kato I, Sato S, Kashiwabara T, Furuta S, Sato H, Tanikawa K, Kumashiro R, Kanayama M.
    Gastroenterol Jpn; 1992 Feb 31; 27(1):61-8. PubMed ID: 1313384
    [Abstract] [Full Text] [Related]

  • 14. [Serum levels of cholylglycine and sulfolitho-cholylglycine in the course of acute hepatitis (author's transl)].
    Ohlen J, Richter J, Neiss A, Drescher M, Selmair H.
    Acta Med Austriaca; 1981 Feb 31; 7(2):49-51. PubMed ID: 7211138
    [Abstract] [Full Text] [Related]

  • 15. Specific 125I-radioimmunoassay for cholyglycine, a bile acid, in serum.
    Miller P, Weiss S, Cornell M, Dockery J.
    Clin Chem; 1981 Oct 31; 27(10):1698-703. PubMed ID: 7285320
    [Abstract] [Full Text] [Related]

  • 16. [Clinical significance of serum bile acid radioimmunoassay in hepatobiliary diseases--with special reference to the CG/SLCG ratio (author's transl)].
    Oshiumi Y, Koga S, Kamoi I, Nishitani H, Ichiya Y, Ibayashi H, Matsuura K.
    Radioisotopes; 1979 Oct 15; 28(10):630-5. PubMed ID: 531242
    [Abstract] [Full Text] [Related]

  • 17. A correlative study on serum cholylglycine levels in hepatobiliary disease.
    Qui BS, Cho CH, Ogle CW.
    Horm Metab Res; 1992 Sep 15; 24(9):443-5. PubMed ID: 1427617
    [Abstract] [Full Text] [Related]

  • 18. Glycocholic acid in chronic active hepatitis and mild liver diseases.
    Collazos J.
    Clin Investig; 1993 Dec 15; 72(1):36-9. PubMed ID: 8136614
    [Abstract] [Full Text] [Related]

  • 19. [Serum bile acids in hepatobiliary disease].
    Esquivel López A, González Espinola G, Gutiérrez Nava R, García Arreola RM.
    Rev Gastroenterol Mex; 1982 Dec 15; 47(1):9-12. PubMed ID: 7100761
    [No Abstract] [Full Text] [Related]

  • 20. Serum glycine-conjugated bile acids in pediatric hepatobiliary disorders.
    Lloyd-Still JD, Demers LM.
    Am J Clin Pathol; 1979 Apr 15; 71(4):444-51. PubMed ID: 443203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.